SecBot SecBot
8-K ·Filed Sep 14, 2026

CABA

Cabaletta Bio, Inc.
NEUTRAL
Impact 4/10
Horizonimmediate Processed2mo ago SEC0001759138-26-000041
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The massive near-expiration exercise wave suggests the stock traded above the $2.50 warrant price throughout Q3 2026, which is consistent with a $463M market cap. With the warrant overhang now largely extinguished (only ~1.8M warrants unexercised), the primary equity overhang is removed. Monitor upcoming Q3 2026 financials for the cash balance impact and any forward guidance on pipeline spending.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$2.91
T+0 close · Sep 14, 2026 · via day close
Latest settled
−38.49%
T+20 · $1.79 · next T+60 in 21d
Vs SPY
−40.75%
α at T+20
Latest observation
−51.55%
T+44 · FF3 residual α
  1. T+0 · Sep 14 $2.91entry
  2. T+1 · 2mo ago −10.82%α −10.37% · $2.60
  3. T+5 · 8w ago −15.46%α −15.57% · $2.46
  4. T+20 · 5w ago −38.49%α −40.75% · $1.79
  5. T+45 · todayOpen
  6. T+60 · in 21d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Cabaletta Bio reports that warrants issued in a June 2025 public offering expired on September 12, 2026, and that 97% (46.0M of 53.1M) were exercised in the three months before expiration, generating $115M in aggregate gross proceeds in Q3 2026 and ~$128.2M total since issuance. The filing is a routine update on warrant exercise activity and contains no new operational or pipeline developments.

Key Facts

  • 53,090,190 common stock warrants were issued in June 2025 with a $2.50 exercise price and an expiration date of September 12, 2026.
  • 5,275,100 warrants were exercised from issuance through June 30, 2026, generating ~$13.2M in gross proceeds.
  • 46,011,900 warrants were exercised from July 1, 2026 through the expiration date, generating ~$115.0M in aggregate gross proceeds.
  • Total aggregate gross proceeds from all warrant exercises: approximately $128.2 million.

Financial Impact

Cabaletta received approximately $128.2 million in gross proceeds from warrant exercises, including ~$115.0M in the last ~2.5 months before expiration.

cash_and_cash_equivalents

Risk Factors

  • Dilution from the remaining ~1.8M warrants that were not exercised is minimal.
  • The ~$128M cash infusion could pressure management to show progress on pipeline catalysts to justify the stock's valuation.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001759138-26-000041
Document: 0001759138-26-000041-index-headers.html0001759138-26-000041
Document: 0001759138-26-000041-index.html0001759138-26-000041
Document: 0001759138-26-000041.txt0001759138-26-000041

Track record

29 reports on CABA

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +31.59% at T+60 after the May 4, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $1.15 Now $1.11 −3.09% settles Nov 23
  2. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.32 Now $1.11 −15.91% settles Nov 23
  3. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $1.33 Now $1.11 −16.54% settles Nov 19
  4. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $1.45 Now $1.11 −23.45% settles Nov 17
  5. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
  6. Nov 8, 20268d ago Press Release Bullish 6/10 Entry $1.50 to $1.11 Now $1.11 −26.00% ▼ −26.00% −24.31% vs SPY
  7. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
  8. Nov 6, 202610d ago SC 13G/A Neutral 2/10 Entry $1.30 to $1.28 Now $1.11 −14.62% ▼ −1.54% −4.13% vs SPY
  9. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $1.28 to $1.33 Now $1.11 −13.28% ▲ +3.91% +0.62% vs SPY
  10. Nov 5, 202611d ago Press Release Neutral 4/10 No price data
Showing 10 of 29

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026